Open: 3.14 Close: 2.91 Change: -0.23

Today's Summary

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. Absci is advancing the future of drug discovery with generative design. Absci Corp. is a penny stock with a market cap of just $600 million. As this trend grows across the biotech space, Absci is on the cutting edge, giving it the potential to lead a new generation of companies creating new medicines. Despite the significant potential for Absci, the company presents execution risks.